Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Design of novel Magnetic Graphene Oxide Nanozyme platform for Theranostic applications

Description du projet

Une plateforme hybride pour provoquer la mort des cellules cancéreuses

Il est essentiel de s’intéresser aux mécanismes inhérents à la mort des cellules cancéreuses pour produire des matériaux multifonctionnels efficaces destinés à des applications oncologiques. Financé par le programme Actions Marie Skłodowska-Curie, le projet MagGraphZyme entend développer une plateforme hybride pour provoquer la production intracellulaire d’espèces réactives de l’oxygène/azote (ROS/RNS). Ces espèces seront utilisées pour provoquer la mort des cellules cancéreuses. Afin d’améliorer la production de ROS/RNS, la plateforme proposée s’appuiera sur des nanoparticules magnétiques, des oxydes de graphène N-décorés et une enveloppe en polymère (PLGA). En outre, certaines voies de signalisation seront étudiées afin de mieux comprendre les différentes voies cellulaires impliquées dans la toxicité et la mort définitive des cellules.

Objectif

MagGraphZyme aims at the development of a new hybrid multiplatform capable of triggering the intracellular production of reactive oxygen/nitrogen species (ROS/RNS) for inducing cell death in cancer cells. The proposed hybrid nanosystem, based on the combination of magnetic nanoparticles (MNPs), nitrogen doped graphene oxide (N-GO) and a polymer (PLGA) shell, will improve ROS/RNS production due to the synergistic effects of all components regarding their catalytic activity as peroxidase-mimetic nanozymes. The control of this catalytic activity will be performed by heating the intracellular level via the activation of the constituent MNPs through a remotely applied magnetic field. Thus, a novel approach for intracellular ROS/RNS production and quantification will be implemented. Furthermore, with the aim of understanding the different cells’ pathways involved in the toxicity and the final death of the cells, these hybrid system will be evaluated to investigate pathway-specific ROS/RNS induction of apoptosis and ROS-response mechanisms. Thus, I will study signaling pathways which are known to be influenced by the production of these species. To this end, I propose detailed physical and chemical studies, down to the atomic level, of the MNPs@N-GO-PLGA systems for identifying the relationships between catalytic efficacy and active atomic sites within the structures. These works will be developed by a motivated researcher with a strong background in MNPs, who will enhance and diversify his skills in advanced microscopy techniques and will acquire competences in bio-medicine. This multidisciplinary and innovative proposal will strengthen the collaboration between the hosting institutions, will enable the European hosting institution to reinforce crucial competences in the understanding & production of multifunctional materials and will contribute to improving oncological applications, which is one of the most important scientific challenges with a high social impact.

Régime de financement

MSCA-PF - MSCA-PF

Coordinateur

UNIVERSIDAD DE ZARAGOZA
Contribution nette de l'UE
€ 261 380,64
Adresse
CALLE PEDRO CERBUNA 12
50009 Zaragoza
Espagne

Voir sur la carte

Région
Noreste Aragón Zaragoza
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Partenaires (1)